Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
Status:
Recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to
placebo in the treatment of allergic conjunctivitis using an antigen challenge model